| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |